← Back to Search

Stem Cell Therapy

Microcannula Harvest Adipose for Cortical Basal Ganglionic Degeneration (NDD Trial)

N/A
Waitlist Available
Led By Ryan Welter, MD, PhD
Research Sponsored by Regeneris Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month interval for up to 5 years
Awards & highlights

NDD Trial Summary

This trial is testing whether it is safe and effective to use a person's own stem cells to treat neurological diseases.

Eligible Conditions
  • Cortical Basal Ganglionic Degeneration
  • Dementia
  • Parkinson's Disease
  • Alzheimer's Disease
  • Autoimmune Diseases of the Central Nervous System
  • Peripheral Neuropathy
  • Corticobasal Degeneration Syndrome

NDD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month interval for up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month interval for up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participant with adverse events (AE) or severe adverse events (SAE)
Secondary outcome measures
Magnetic Resonance Imaging (MRI)
Neurological Function
Neurological Tested Functions

NDD Trial Design

3Treatment groups
Experimental Treatment
Group I: Sterile Normal Saline InfusionExperimental Treatment1 Intervention
Sterile Normal Saline to Re-Suspend Autologous cSVF pellet for delivery via intravascular (IV) route
Group II: Microcannula Harvest AdiposeExperimental Treatment1 Intervention
Acquisition AD-tSVF Via Closed Syringe Microcannula
Group III: Centricyte 1000Experimental Treatment1 Intervention
Autologous Adipose-Derived Tissue Stromal Vascular Fraction (tSVF) via enzymatic digestive isolation & concentration in Centricyte 1000 closed system to create AD-cSVF

Find a Location

Who is running the clinical trial?

Global Alliance for Regenerative MedicineOTHER
4 Previous Clinical Trials
460 Total Patients Enrolled
Regeneris MedicalLead Sponsor
3 Previous Clinical Trials
380 Total Patients Enrolled
Regeneris Medical IncUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment available to participants of 18 years or older?

"This clinical trial is accepting patients aged 18 to 90. There are 49 trials that focus on younger individuals, and 795 studies devoted to those over 65 years old."

Answered by AI

Is this clinical investigation currently seeking participants?

"According to the clinicaltrials.gov archives, this particular trial is not enrolling patients at present. First listed on January 1st 2020 and last updated on October 17th 2018, it does not currently have an open call for participants; however there are 821 other trials actively searching for volunteers."

Answered by AI

What qualifications must one meet in order to be considered for this research project?

"This clinical trial is searching for 300 participants who are living with dementia and aged between 18 to 90. To qualify, they must meet the following criteria: a documented neurological impairment that cannot be effectively treated using current standard of care approaches; 6 months or more have passed since initial onset/diagnosis; their existing medical therapy has proven unsuccessful and/or intolerable; able to participate in neurologic exams conducted by investigators or their own specialists; capable and competent enough to provide informed consent for study participation; minimal risk associated with collection of autologous stem cell samples."

Answered by AI
Recent research and studies
~57 spots leftby Apr 2025